1
|
Gao X, Zhang M, Yang Z, Niu X, Zhou B, Chen J, Wang W, Wei Y, Han S, Cheng J, Zhang Y. Nicotine addiction and overweight affect intrinsic neural activity and neurotransmitter activity: A fMRI study of interaction effects. Psychiatry Clin Neurosci 2023; 77:178-185. [PMID: 36468828 DOI: 10.1111/pcn.13516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 10/11/2022] [Accepted: 11/28/2022] [Indexed: 12/12/2022]
Abstract
BACKGROUND Nicotine addiction and overweight often co-exist, but the neurobiological mechanism of their co-morbidity remains to be clarified. In this study, we explore how nicotine addiction and overweight affect intrinsic neural activity and neurotransmitter activity. METHODS This study included 54 overweight people and 54 age-, sex-, and handedness-matched normal-weight individuals, who were further divided into four groups based on nicotine addiction. We used a two-way factorial design to compare intrinsic neural activity (calculated by the fALFF method) in four groups based on resting-state functional magnetic resonance images (rs-fMRI). Furthermore, the correlation between fALFF values and PET- and SPECT-derived maps to examine specific neurotransmitter system changes underlying nicotine addiction and overweight. RESULTS Nicotine addiction and overweight affect intrinsic neural activity by themselves. In combination, they showed antagonistic effects in the interactive brain regions (left insula and right precuneus). Cross-modal correlations displayed that intrinsic neural activity changes in the interactive brain regions were related to the noradrenaline system (NAT). CONCLUSION Due to the existence of interaction, nicotine partially restored the changes of spontaneous activity in the interactive brain regions of overweight people. Therefore, when studying one factor alone, the other should be used as a control variable. Besides, this work links the noradrenaline system with intrinsic neural activity in overweight nicotine addicts. By examining the interactions between nicotine addiction and overweight from neuroimaging and molecular perspectives, this study provides some ideas for the treatment of both co-morbidities.
Collapse
Affiliation(s)
- Xinyu Gao
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Mengzhe Zhang
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Zhengui Yang
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Xiaoyu Niu
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Bingqian Zhou
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Jingli Chen
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Weijian Wang
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Yarui Wei
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Shaoqiang Han
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Jingliang Cheng
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| | - Yong Zhang
- Department of Magnetic Resonance Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.,Key Laboratory for Functional Magnetic Resonance Imaging and Molecular imaging of Henan Province, Henan, China.,Engineering Technology Research Center for detection and application of brain function of Henan Province, Henan, China.,Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Henan, China.,Key Laboratory of Magnetic Resonance and Brain Function of Henan Province, Henan, China.,Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, China.,Key Laboratory of Imaging Intelligence Research medicine of Henan Province, Henan, China.,Engineering Research Center of Brain Function Development and Application of Henan Province, Henan, China
| |
Collapse
|
2
|
Lv L, Zhang H, Tan X, Qin L, Peng X, Bai R, Xiao Q, Tan C, Liao H, Yan W, Tan J, Tang B, Wang C. Assessing the Effects of Vitamin D on Neural Network Function in Patients With Parkinson's Disease by Measuring the Fraction Amplitude of Low-Frequency Fluctuation. Front Aging Neurosci 2022; 13:763947. [PMID: 34987377 PMCID: PMC8721225 DOI: 10.3389/fnagi.2021.763947] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Accepted: 11/17/2021] [Indexed: 11/13/2022] Open
Abstract
Background: Recently, many studies have shown that low vitamin D (VD) levels may be related to an increased risk of Parkinson's disease (PD), but the underlying mechanisms remain unclear. Objective: To explore the relationship between PD and VD levels, as well as to analyze the effects of VD on spontaneous brain activity and explore the possible mechanism of its involvement in PD risk. Methods: In a cross-sectional study, we quantified the difference in VD levels between 330 PD patients and 209 healthy controls (HC) to explore the correlation between VD and PD risk. We also acquired resting-state Functional Magnetic Resonance Imaging (rs-fMRI) data from 46 PD patients and 21 HC. The PD patients were divided into three groups according to 25(OH)D levels: PD patients with VD deficiency (PD + VDD), PD patients with VD insufficiency (PD + VDI), and PD patients with normal VD (PD + NVD). The effect of VD status on spontaneous neuronal activity in the whole brain was analyzed by measuring the fraction amplitude of low-frequency fluctuation (fALFF). Results: Compared with HC, the PD patients had lower serum 25(OH)D levels (23.60 ± 7.27 vs. 25.60 ± 5.78, P < 0.001). The 25(OH)D level may have a potential dose-dependent effect on the risk of PD (P trend = 0.007). A high risk of PD was associated with VD deficiency [25(OH)D < 20 ng/mL, OR = 2.319], and the lowest quartile of 25(OH)D concentration was associated with a high risk of PD (OR = 1.941). In the rs-fMRI study, PD + VDD patients had wider brain regions with altered fALFF than other PD groups when compared with the corresponding HC groups. Both PD + VDD and PD + VDI showed higher fALFF in the cuneus, left precuneus, calcarine cortex and right lingual, as well as lower fALFF in the left middle temporal gyrus. PD + VDD patients also showed higher fALFF in the left superior, middle and inferior frontal gyri, as well as the left precentral gyrus than HC. Among PD patients, there was only a statistically significant difference in fALFF between the PD + VDD and PD + NVD groups. Compared with the PD + NVD group, PD + VDD patients exhibited higher fALFF in the left precentral and left postcentral gyrus, as well as the left inferior parietal lobule. Conclusion: These results demonstrate that PD patients had lower serum VD levels than HC, and VD may have a potential dose-dependent effect on PD risk. Lower serum VD levels can affect the spontaneous neuronal activity of default-mode network (DMN) and visual pathway neurons in PD patients, providing a possible mechanism for its effect on PD risk.
Collapse
Affiliation(s)
- Lingling Lv
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Hainan Zhang
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Xuling Tan
- Department of Medical Genetics, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Lixia Qin
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Xinke Peng
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Rongrong Bai
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Qile Xiao
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Changlian Tan
- Department of Radiology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Haiyan Liao
- Department of Radiology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Weiqian Yan
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Jieqiong Tan
- Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.,Hunan Key Laboratory of Animal Models for Human Diseases, Central South University, Changsha, China.,Hunan Key Laboratory of Medical Genetics, Central South University, Changsha, China
| | - Beisha Tang
- Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.,National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.,Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.,Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China
| | - Chunyu Wang
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, China.,Department of Medical Genetics, The Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|